Saul Genuth

19.8k citations

112 papers · 11.9k indexed · 1 hit paper · h-index 43

Impact in

Endocrinology, Diabetes and Metabolism top 0.05%
- Diabetes Treatment and Management
- Diabetes Management and Research
- Diabetes, Cardiovascular Risks, and Lipoproteins
Clinical Biochemistry top 0.1%
- Advanced Glycation End Products research

Papers in

Endocrinology, Diabetes and Metabolism 78
- Diabetes Management and Research 42
- Diabetes, Cardiovascular Risks, and Lipoproteins 30
- Diabetes Treatment and Management 23
Clinical Biochemistry 16
- Advanced Glycation End Products research 13

Co-authors: Faramarz Ismail‐Beigi Hertzel C. Gerstein David C. Goff Richard H. Grimm William C. Cushman John B. Buse Denise G. Simons‐Morton Robert P. Byington
Journals: Diabetes (21 papers)Diabetes Care (11 papers)The Journal of Clinical Endocrinology & Metabolism (9 papers)Metabolism (7 papers)Annals of Internal Medicine (5 papers)
Partner nations: United States Canada Austria

In The Last Decade

Saul Genuth

111 papers receiving 11.2k citations

Hit Papers

align trajectories log scale

Effects of Intensive Glucose Lowering in Type 2 Diabetes 2008 · 5.5k citations

Peers

Countries citing papers authored by Saul Genuth

Since Specialization

Citations

This map shows the geographic impact of Saul Genuth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Saul Genuth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Saul Genuth more than expected).

Fields of papers citing papers by Saul Genuth

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Saul Genuth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Saul Genuth. The network helps show where Saul Genuth may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Saul Genuth, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Saul Genuth Line = papers co-authored together Saul Genuth links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	BARI 2D: A Reanalysis Focusing on Cardiovascular Events Mayo Clinic Proceedings ·Saul Genuth, Helen Vlachos, Maria M. Brooks, John P. Bantle, Bernard Chaitman, Jennifer Green, Sheryl F. Kelsey, Spencer B. King, Robert D. McBane, Edward Y. Sako, David J. Schneider, Michael W. Steffes, Robert L. Frye	2019	1
2	Cardiovascular Autonomic Neuropathy and Cardiovascular Outcomes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Diabetes Care ·Rodica Pop‐Busui, Barbara H. Braffett, B. Zinman, Catherine L. Martin, Neil H. White, William H. Herman, Saul Genuth, Rose Gubitosi‐Klug	2016	78
3	Skin collagen fluorophore LW-1 versus skin fluorescence as markers for the long-term progression of subclinical macrovascular disease in type 1 diabetes Cardiovascular Diabetology ·David R. Sell, Wanjie Sun, Xiaoyu Gao, Christopher Strauch, John M. Lachin, Patricia A. Cleary, Saul Genuth, Vincent M. Monnier	2016	21
4	Skin collagen advanced glycation endproducts (AGEs) and the long-term progression of sub-clinical cardiovascular disease in type 1 diabetes Cardiovascular Diabetology ·Vincent M. Monnier, Wanjie Sun, Xiaoyu Gao, David R. Sell, Patricia A. Cleary, John M. Lachin, Saul Genuth	2015	51
5	Insulin Dose and Cardiovascular Mortality in the ACCORD Trial Diabetes Care ·Elias S. Siraj, Daniel J. Rubin, Matthew C. Riddle, Michael E. Miller, Fang‐Chi Hsu, Faramarz Ismail‐Beigi, リーアンシン, Walter T. Ambrosius, Abraham Thomas, William H. Bestermann, John B. Buse, Saul Genuth, Carol Joyce, Christopher S. Kovács, Patrick J. O’Connor, Ronald J. Sigal, Mateja Mandac, (unknown)	2015	28
6	The Effects of Medical Management on the Progression of Diabetic Retinopathy in Persons with Type 2 Diabetes Ophthalmology ·Emily Y. Chew, Matthew D. Davis, Ronald P. Danis, James Lovato, Letitia Perdue, Craig M. Greven, Saul Genuth, David C. Goff, Lawrence A. Leiter, Faramarz Ismail‐Beigi, Walter T. Ambrosius	2014	229
7	Glucosepane: a poorly understood advanced glycation end product of growing importance for diabetes and its complications Clinical Chemistry and Laboratory Medicine (CCLM) ·Vincent M. Monnier, Wanjie Sun, David R. Sell, Xingjun Fan, Ina Nemet, Saul Genuth	2013	57
8	Haptoglobin Genotype and the Rate of Renal Function Decline in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study Diabetes ·Trevor J. Orchard, Wanjie Sun, Patricia A. Cleary, Saul Genuth, John M. Lachin, Paula McGee, Andrew D. Paterson, Philip Raskin, Yefim Anbinder, Andrew P. Levy	2013	33
9	Determinants of successful glycemic control among participants in the BARI 2D Trial: A Post-hoc Analysis Journal of Diabetes and its Complications ·Faramarz Ismail‐Beigi, M. Lombardero, Jorge Escobedo, Saul Genuth, Jennifer Green, Elaine Massaro, Arshag D. Mooradian, Fernando Ovalle, Fred W. Whitehouse, Joel Zonszein	2013	2
10	Haptoglobin Genotype and the Rate of Renal Function Decline in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study Diabetes Care ·Trevor J. Orchard, Wanjie Sun, Patricia A. Cleary, Saul Genuth, John M. Lachin, Paula McGee, Andrew D. Paterson, Philip Raskin, Yefim Anbinder, Andrew P. Levy, K Maruyama	2013	3
11	Myocardial Structure, Function, and Scar in Patients With Type 1 Diabetes Mellitus Circulation ·Evrim Türkbey, Jye‐Yu C. Backlund, Saul Genuth, Aditya Jain, 苗恒, Patricia A. Cleary, John M. Lachin, David M. Nathan, Rob J. van der Geest, Elsayed Z. Soliman, Chia‐Ying Liu, João A.C. Lima, David A. Bluemke	2011	72
12	Effects of Cardiac Autonomic Dysfunction on Mortality Risk in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial Diabetes Care ·Rodica Pop‐Busui, Gregory W. Evans, Hertzel C. Gerstein, Vivian Fonseca, Jerome L. Fleg, Byron J. Hoogwerf, Saul Genuth, Richard H. Grimm, Marshall A. Corson, Ronald J. Prineas, (unknown)	2010	349
13	The UKPDS and its global impact Diabetic Medicine ·Saul Genuth	2008	24
14	Rationale, Design, and Methods of the Action to Control Cardiovascular Risk in Diabetes Eye Study (ACCORD-EYE) The American Journal of Cardiology ·Emily Y. Chew, Walter T. Ambrosius, Ratna Nurul Komariah, Craig M. Greven, Samantha Johnson, Ronald P. Danis, Matthew D. Davis, Saul Genuth, Michaël Domanski	2007	48
15	Prevention of Cardiovascular Disease in Persons with Type 2 Diabetes Mellitus: Current Knowledge and Rationale for the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial The American Journal of Cardiology ·David C. Goff, Hertzel C. Gerstein, Henry N. Ginsberg, William C. Cushman, Karen L. Margolis, Robert P. Byington, John B. Buse, Saul Genuth, Jeffrey L. Probstfield, Denise G. Simons‐Morton	2007	180
16	The Effect of Intensive Glycemic Treatment on Coronary Artery Calcification in Type 1 Diabetic Participants of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Diabetes ·Patricia A. Cleary, Trevor J. Orchard, Saul Genuth, Nathan D. Wong, Robert Detrano, 美帆子西村, Bernard Zinman, Alan M. Jacobson, Wanjie Sun, John M. Lachin, David M. Nathan	2006	190
17	Insights from The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study on The Use of Intensive Glycemic Treatment to Reduce The Risk of Complications of Type 1 Diabetes Endocrine Practice ·Saul Genuth	2006	100
18	Implications of the United Kingdom Prospective Diabetes Study for Patients with Obesity and Type 2 Diabetes Obesity Research ·Saul Genuth	2000	8
19	Urinary 3-hydroxyadipic acid 3,6-lactone: Structural identification and effect of fasting in adults and children Metabolism ·Kou‐Yi Tserng, 憲二平野, Charles L. Hoppel, Douglas S. Kerr, Saul Genuth	1989	14
20	Hyperinsulinism in obese diabetic Pima Indians Metabolism ·Saul Genuth, Peter H. Bennett, Max Miller, T. A. Burch	1967	21

About Saul Genuth

Saul Genuth is a scholar working on Endocrinology, Diabetes and Metabolism, Clinical Biochemistry, Physiology, Nephrology and Cardiology and Cardiovascular Medicine, having authored 112 papers that have together received 11.9k indexed citations. Recurring topics across this work include Diabetes Management and Research (42 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (30 papers), Diabetes Treatment and Management (23 papers), Diet and metabolism studies (17 papers), Diabetes and associated disorders (14 papers), Metabolism, Diabetes, and Cancer (14 papers), Pancreatic function and diabetes (14 papers) and Advanced Glycation End Products research (13 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (7.3k citations), Clinical Biochemistry (1.3k citations), Nephrology (695 citations), Cardiology and Cardiovascular Medicine (2.2k citations) and Physiology (1.6k citations). Saul Genuth has collaborated with scholars based in United States, Canada and Austria. Frequent co-authors include Faramarz Ismail‐Beigi, Hertzel C. Gerstein, David C. Goff, Richard H. Grimm, William C. Cushman, John B. Buse, Denise G. Simons‐Morton, Robert P. Byington, Michael E. Miller and J. Thomas Bigger. Their work appears in journals such as Diabetes, Diabetes Care, The Journal of Clinical Endocrinology & Metabolism, Metabolism and Annals of Internal Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact